Multiple endocrine neoplasia type 2: Difference between revisions
No edit summary |
(Mahshid) |
||
(26 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
'''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | |||
{{ | |||
{{Multiple endocrine neoplasia type 2}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
{{SK}} Multiple endocrine adenomatosis | {{SK}} Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome | ||
==[[Multiple endocrine neoplasia type 2 overview|Overview]]== | ==[[Multiple endocrine neoplasia type 2 overview|Overview]]== | ||
==[[Multiple endocrine neoplasia type 2 historical perspective|Historical Perspective]]== | ==[[Multiple endocrine neoplasia type 2 historical perspective|Historical Perspective]]== | ||
==[[Multiple endocrine neoplasia type 2 classification|Classification]]== | |||
==[[Multiple endocrine neoplasia type 2 pathophysiology|Pathophysiology]]== | ==[[Multiple endocrine neoplasia type 2 pathophysiology|Pathophysiology]]== | ||
==[[Multiple endocrine neoplasia type 2 causes|Causes]]== | |||
==[[Multiple endocrine neoplasia type 2 differential diagnosis|Differentiating Multiple endocrine neoplasia type 2 from other Diseases]]== | |||
==[[Multiple endocrine neoplasia type 2 epidemiology and demographics|Epidemiology & Demographics]]== | ==[[Multiple endocrine neoplasia type 2 epidemiology and demographics|Epidemiology & Demographics]]== | ||
Line 41: | Line 23: | ||
==[[Multiple endocrine neoplasia type 2 screening|Screening]]== | ==[[Multiple endocrine neoplasia type 2 screening|Screening]]== | ||
==[[Multiple endocrine neoplasia type 2 natural history|Natural History, Complications & Prognosis]]== | ==[[Multiple endocrine neoplasia type 2 natural history|Natural History, Complications & Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Multiple endocrine neoplasia type 2 history and symptoms|History & Symptoms]] | [[Multiple endocrine neoplasia type 2 physical examination|Physical Examination]] | [[Multiple endocrine neoplasia type 2 laboratory | [[Multiple endocrine neoplasia type 2 diagnostic criteria|Diagnostic Criteria]] | [[Multiple endocrine neoplasia type 2 history and symptoms|History & Symptoms]] | [[Multiple endocrine neoplasia type 2 physical examination|Physical Examination]] | [[Multiple endocrine neoplasia type 2 laboratory findings|Laboratory Findings]] | [[Multiple endocrine neoplasia type 2 electrocardiogram|Electrocardiogram]] | [[Multiple endocrine neoplasia type 2 x ray|X Ray]] | [[Multiple endocrine neoplasia type 2 CT|CT]] | [[Multiple endocrine neoplasia type 2 MRI|MRI]] | [[Multiple endocrine neoplasia type 2 echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Multiple endocrine neoplasia type 2 other imaging findings|Other Imaging Findings]] | [[Multiple endocrine neoplasia type 2 other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
Line 59: | Line 35: | ||
* [[Multiple endocrine neoplasia]] | * [[Multiple endocrine neoplasia]] | ||
* [[Multiple endocrine neoplasia type 1]] | * [[Multiple endocrine neoplasia type 1]] | ||
* [[Multiple endocrine neoplasia type 4]] | |||
{{Endocrine pathology}} | {{Endocrine pathology}} | ||
[[Category:Endocrinology]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[ | [[CAtegory:Diseases]] | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:46, 27 November 2017
For patient information, click here.
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 2 from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria | History & Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
See also
- Multiple endocrine neoplasia
- Multiple endocrine neoplasia type 1
- Multiple endocrine neoplasia type 4